These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21704110)

  • 1. Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection.
    Voytek CD; Jones KT; Metzger DS
    Vaccine; 2011 Aug; 29(36):6130-5. PubMed ID: 21704110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment.
    Newman PA; Duan N; Roberts KJ; Seiden D; Rudy ET; Swendeman D; Popova S
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):210-7. PubMed ID: 16394854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. African-American and Hispanic perceptions of HIV vaccine clinical research: a qualitative study.
    Toledo L; McLellan-Lemal E; Arreola S; Campbell C; Sutton M
    Am J Health Promot; 2014; 29(2):e82-90. PubMed ID: 24432823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decisions to participate in research: views of underserved minority drug users with or at risk for HIV.
    Slomka J; Ratliff EA; McCurdy SA; Timpson S; Williams ML
    AIDS Care; 2008 Nov; 20(10):1224-32. PubMed ID: 18608070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies.
    Dhalla S; Poole G
    AIDS Care; 2011 Nov; 23(11):1430-47. PubMed ID: 21722022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motivators to participation in actual HIV vaccine trials.
    Dhalla S; Poole G
    AIDS Behav; 2014 Feb; 18(2):263-77. PubMed ID: 23736885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
    Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
    BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities.
    Strauss RP; Sengupta S; Kegeles S; McLellan E; Metzger D; Eyre S; Khanani F; Emrick CB; MacQueen KM
    J Acquir Immune Defic Syndr; 2001 Jan; 26(1):63-71. PubMed ID: 11176270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
    Connochie D; Tingler RC; Bauermeister JA
    Vaccine; 2019 Oct; 37(43):6494-6499. PubMed ID: 31522806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study.
    Mayanja Y; Abaasa A; Namale G; Price MA; Kamali A
    BMC Public Health; 2020 Nov; 20(1):1789. PubMed ID: 33239018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand.
    Jenkins RA; Chinaworapong S; Morgan PA; Ruangyuttikarn C; Sontirat A; Chiu J; Michael RA; Nitayaphan S; Khamboonruang C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):171-7. PubMed ID: 9637582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Once I begin to participate, people will run away from me": understanding stigma as a barrier to HIV vaccine research participation in Kenya.
    Nyblade L; Singh S; Ashburn K; Brady L; Olenja J
    Vaccine; 2011 Nov; 29(48):8924-8. PubMed ID: 21964057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.
    Tarimo EA; Thorson A; Kohi TW; Mwami J; Bakari M; Sandström E; Kulane A
    BMC Public Health; 2010 May; 10():292. PubMed ID: 20509908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV vaccine trial preparedness among Spanish-speaking Latinos in the US.
    Brooks RA; Newman PA; Duan N; Ortiz DJ
    AIDS Care; 2007 Jan; 19(1):52-8. PubMed ID: 17129857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.
    Asiki G; Abaasa A; Ruzagira E; Kibengo F; Bahemuka U; Mulondo J; Seeley J; Bekker LG; Delany S; Kaleebu P; Kamali A
    Vaccine; 2013 Oct; 31(44):5055-61. PubMed ID: 24021306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City.
    Richardson S; Seekaew P; Koblin B; Vazquez T; Nandi V; Tieu HV
    PLoS One; 2017; 12(7):e0181702. PubMed ID: 28723970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya.
    Jackson DJ; Martin HL; Bwayo JJ; Nyange PM; Rakwar JP; Kashonga F; Mandaliya K; Ndinya-Achola JO; Kreiss JK
    AIDS; 1995 Nov; 9(11):1279-83. PubMed ID: 8561982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using surrogate vaccines to assess feasibility and acceptability of future HIV vaccine trials in men: a randomised trial in inner-city Johannesburg, South Africa.
    Chimoyi L; Kamndaya M; Venables E; von Knorring N; Stadler J; MacPhail C; Chersich MF; Rees H; Delany-Moretlwe S
    BMC Public Health; 2017 Jul; 17(Suppl 3):524. PubMed ID: 28832280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania.
    Tarimo EA; Bakari M; Kakoko DC; Kohi TW; Mhalu F; Sandstrom E; Kulane A
    BMC Public Health; 2016 Feb; 16():182. PubMed ID: 26911203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.